Keywords: Androgen receptor; CYP17A1; Disorders of sex development; Exome sequencing; SRD5A2; DSD; disorders of sex development; NGS; next-generation sequencing; VUS; variants of uncertain clinical significance;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: SNP; SRD5A1; SRD5A2; CYP17A1; Prostate cancer; OpenArray;
Keywords: Disorder of sexual development; Lipoid congenital adrenal hyperplasia; CYP11A1; HSD3B2; CYP17A1; HSD17B3; SRD5A2; POR and CYB5 deficiencies; AKR1C2/4 genesTroubles du développement sexuel; Hyperplasie congénitale lipoide des surrénales; Déficits en CYP11A
Inefficient UGT-conjugation of adrenal 11β-hydroxyandrostenedione metabolites highlights C11-oxy C19 steroids as the predominant androgens in prostate cancer
Keywords: UDP; uridine diphosphate; UGT; UDP-glucuronosyltransferases; 17βHSD; 17β-hydroxysteroid dehydrogenase; AKR1C3; 17β-hydroxysteroid dehydrogenase type 5; 11βHSD2; 11β-hydroxysteroid dehydrogenase type 2; SRD5A; 5α-reductase; SRD5A1; 5α-reductase type
Genotype-phenotype correlation and identification of two novel SRD5A2 mutations in 33 Chinese patients with hypospadias
Keywords: Hypospadias; SRD5A2; AR; HSD17B; Mutation;
Fetal alpha 5-reductase Val89Leu mutation is associated with late miscarriage
Keywords: CYP19A1; ESR1; Miscarriage; Spontaneous pregnancy loss; SRD5A2;
Prenatal exposure to di-n-butyl phthalate (DBP) differentially alters androgen cascade in undeformed versus hypospadiac male rat offspring
Keywords: DBP; di-n-butyl phthalate; EEDs; environmental endocrine disrupting compounds; AR; Androgen receptor; Srd5a2; steroid-5-alpha-reductase, alpha polypeptide 2; BW; body weight; GD; gestation day; PND; postnatal day; GT; genital tubercle; real-time PCR; real
Testicular disorder of sex development in four cats with a male karyotype (38,XY; SRY-positive)
Keywords: Testicular DSD; Hypospadias; SRY; AR; SRD5A2; MAMLD1;
Next-generation steroidogenesis inhibitors, dutasteride and abiraterone, attenuate but still do not eliminate androgen biosynthesis in 22RV1 cells in vitro
Keywords: DHEA; dehydroepiandrosterone; DHT; dihydrotestosterone; LHRH; luteinizing hormone releasing hormone; LH; luteinizing hormone; AR; androgen receptor; CRPC; castration resistant prostate cancer; PSA; prostate specific antigen; SRD5A1/2; 5-alpha-reductase is
Short CommunicationAmbiguous external genitalia due to defect of 5-α-reductase in seven Iraqi patients: Prevalence of a novel mutation
Keywords: AR; androgen receptor; DHT; dihydrotestosterone; DSD; sex development disorder; hCG; human chorionic gonadotropin; MRI; magnetic resonance imaging; SRD; steroid 5-α-reductase deficiency; SRD5A2; 5-α-reductase type 2; T; testosterone; 46,XY DSD; Founder
11β-Hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5α-reductase yielding 11β-hydroxy-5α-androstanedione
Keywords: 11KA4; 11-ketoandrostenedione; 11KT; 11-ketotestosterone; 11OH-5α-dione; 11β-hydroxy 5α-androstanedione; 11OH-AST; 11β-hydroxyandrosterone; 11OHA4; 11β-hydroxyandrostenedione; 11OHT; 11β-hydroxytestosterone; 11βHSD; 11β-hydroxysteroid dehydrogenas
Polymorphisms in androgen signaling pathway predisposing to prostate cancer
Keywords: AKR1C3; 3α-hydroxysteroid dehydrogenase; AR; androgen receptor; CNV; copy number variation; CYP; cytochrome P450; DHEA; dehydroepiandrosterone; DHT; dehydrotestosterone; HSD17B; 17β-hydroxysteroid dehydrogenase; HSD3B; hydroxy-δ-5-steroid dehydrogenase
Semen analysis and successful paternity by intracytoplasmic sperm injection in a man with steroid 5α-reductase-2 deficiency
Keywords: Steroid 5α-reductase-2 deficiency; SRD5A2; hypomorphic mutation; semen analysis; intracytoplasmic sperm injection; paternity;
Effect of Puberty Onset on Spontaneous Hepatitis B Virus e Antigen Seroconversion in Men
Keywords: Hepatitis B Virus e Antigen; Puberty; Steroid 5α Reductase Type II; Testosterone; ALT; alanine aminotransferase; AR; androgen receptor; HBeAg; hepatitis B virus e antigen; HBsAg; hepatitis B virus surface antigen; HBV; hepatitis B virus; HCC; hepatocellu
Regulation of steroid 5-α reductase type 2 (Srd5a2) by sterol regulatory element binding proteins and statin
Keywords: Srd5a2; Steroid 5-α reductase type 2; SREBP; sterol regulatory element binding protein; HMG; 3-hydroxy-3-methylglutaryl; ChIP; chromatin immunoprecipitation; qPCR; quantitative PCR; L/E; lovastatin and ezetimibe; LDLR; low density lipoprotein receptor; S
Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer
Keywords: Polymorphism; Androgen receptor; CAG repeats; PSA; Prostate cancer; SRD5A2; CYP17
Low-Activity V89L Variant in SRD5A2 Is Associated with Aggressive Prostate Cancer Risk: An Explanation for the Adverse Effects Observed in Chemoprevention Trials Using 5-Alpha-Reductase Inhibitors
Keywords: Prostate cancer; Aggressiveness; SRD5A2; Polymorphism; Susceptibility; Chemoprevention; 5-Alpha-reductase inhibitors
Aromatase, steroid-5-alpha-reductase type 1 and type 2 mRNA expression in gonads and in brain of Xenopus laevis during ontogeny
Keywords: Development; Sexual differentiation; 5-Alpha-reductase; 5α-R; 5α-Reductase; Srd5a1; Srd5a2; Aromatase; Xenopus laevis
A common polymorphism within the steroid 5-alpha-reductase type 2 gene and timing of menopause in Caucasian women
Keywords: SRD5A2; Gene; Polymorphism; Menopause;
Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population
Keywords: AR CAG repeat; Single nucleotide polymorphisms; Genetic susceptibility; Risk factors; Genotyping; Genomic DNA; SRD5A2; UGT2B15; CYP17; PSA promoter; 5α-Reductase; Genetic polymorphism; Prostate cancer; Family history